Comparison of insulin lispro protamine suspension versus insulin glargine once daily in basal-bolus therapies with insulin lispro in type 2 diabetes patients: a prospective randomized open-label trial
Version of Record online: 27 OCT 2011
© 2011 Blackwell Publishing Ltd
Diabetes, Obesity and Metabolism
Volume 13, Issue 12, pages 1149–1157, December 2011
How to Cite
Koivisto, V., Cleall, S., Pontiroli, A. E. and Giugliano, D. (2011), Comparison of insulin lispro protamine suspension versus insulin glargine once daily in basal-bolus therapies with insulin lispro in type 2 diabetes patients: a prospective randomized open-label trial. Diabetes, Obesity and Metabolism, 13: 1149–1157. doi: 10.1111/j.1463-1326.2011.01484.x
- Issue online: 27 OCT 2011
- Version of Record online: 27 OCT 2011
- Accepted manuscript online: 5 AUG 2011 12:00AM EST
- Date submitted 26 April 2011; date of first decision 20 May 2011; date of final acceptance 2 Aug 2011
Additional Supporting Information may be found in the online version of this article:
Appendix S1. List of participating investigators.
Appendix S2. Dosing algorithm for titration of ILPS and glargine based on blood glucose.
Table S1. Insulin dosing algorithms for basal insulins (ILPS or glargine).
Table S2. Insulin dosing algorithms for bolus injections of insulin lispro.
Figure S1. Median total (top), basal and mealtime (bottom) insulin doses (interquartile range) over time.
|DOM_1484_sm_suppl.doc||128K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.